mid-cap

One US Listed Stock under Watch - RKLB

Sep 09, 2021 | Team Kalkine
One US Listed Stock under Watch - RKLB

 

Rocket Lab USA, Inc.

Rocket Lab USA, Inc. (NASDAQ: RKLB) is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform.

Key Highlights:

  • The company reported a 237% y-o-y growth in revenue to USD 29.472 million in H1FY21. Despite a robust topline, the company reported a net loss of USD 32.547 million, which widened from USD 23.452 million in pcp. The group encountered higher input costs due to research & development expenses, increased launch costs and production costs.
  • Backlog jumped 136% y-o-y to USD 141.4 million in H1FY21, and the company launched three missions during the first half of FY21.
  • Moreover, the company entered into an agreement with Kinéis for five Electron launches to deploy their entire constellation of 25 satellites.
  • Recently, the stock witnessed a healthy rally on the daily price chart and has moved above the upper band of the Bollinger Bands®, indicating the stock is perhaps overbought and due for a price correction or a consolidation. Furthermore, the momentum oscillator RSI (14-Period) is trading at ~77.5 levels, which also indicates that the stock is in overbought zone and there is a deep possibility of price consolidation or correction.

One-Year Technical Price Chart (as on September 08, 2021). Analysis by Kalkine Group

Stock Recommendation: The company offers integrated services related to launching services, spacecraft components, satellites and other spacecraft and on-orbit management solutions and has delivered 105 satellites to orbit for private and public sector organizations. The company has two launch pads at a private orbital launch site located in New Zealand, and a lockdown alert in the country due to the Delta variant outbreak would lead to a delay in the launch activity planned in Q3FY21. Moreover, widening net losses have dampened the company’s financial health, which remains a key concern for the company. Also, technical indicators are reflecting a possibilities of a possible price correction or consolidation. Hence, considering the above factors, we give a ‘Watch’ stance on the stock at the closing price of USD 15.09 on September 08, 2021.

 

*The reference data in this report has been partly sourced from REFINITIV.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.


Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Past performance is not a reliable indicator of future performance.